N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study

Παρόμοια τεκμήρια

• N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
  ανά: Emberson, JR, κ.ά.
  Έκδοση: (2007)
• N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
  ανά: Emberson, J, κ.ά.
  Έκδοση: (2005)
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
  ανά: Collins, R, κ.ά.
  Έκδοση: (2002)
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
  ανά: Heart Protection Study Collaborative Group
  Έκδοση: (2002)
• MRC/BHF Heart Protection Study - Reply
  ανά: Collins, R, κ.ά.
  Έκδοση: (2002)